NEPH - Nephros acquires GenArraytion; terms not disclosed

GenArraytion is a recognized market leader in infectious disease monitoring and measurement.This addition will give Nephros (NEPH) access to GenArraytion’s many proprietary assays, multiplexing technology, and selection methods for detecting waterborne pathogens, and other microorganisms using Polymerase Chain Reaction technology.The Company will combine GenArraytion’s assets into the Nephros Pathogen Detection Systems platform.Andy Astor, CEO of Nephros. “In addition to acquiring GenArraytion’s MultiFLEX® Bioassays and other technologies, Dr. R. Paul Schaudies, GenArraytion’s Chief Executive Officer, will partner with our own Dr. Kimothy Smith, Vice President of Pathogen Detection Systems. Working together, our unified organization will provide customers the ability to use on-site testing with fast, accurate, and actionable data as part of their water management programs.”Press Release

For further details see:

Nephros acquires GenArraytion; terms not disclosed